Diagnostic accuracy of tumour markers for malignant pleural effusion: A meta-analysis

Thorax

Volumn 63, Issue 1, 2008, Pages 35-41

  Liang, Q L ^a   Shi, H Z ^a   Qin, X J ^a   Liang, X D ^a   Jiang, J ^a   Yang, H B ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; TUMOR MARKER; ANTIGEN CYFRA21.1; KERATIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; EVIDENCE BASED PRACTICE; HUMAN; META ANALYSIS; PLEURA EFFUSION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TASK PERFORMANCE; BLOOD; PUBLISHING; REGRESSION ANALYSIS; REVIEW;

ANTIGENS, NEOPLASM; CA-125 ANTIGEN; CA-15-3 ANTIGEN; CA-19-9 ANTIGEN; HUMANS; KERATINS; PLEURAL EFFUSION, MALIGNANT; PUBLICATION BIAS; REGRESSION ANALYSIS;

EID: 38349108165     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2007.077958     Document Type: Article

References (27)

1. American Thoracic Society. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000;162:1987-2001.
2. Bennett R, Maskell N. Management of malignant pleural effusions. Curr Opin Pulm Med 2005;11:296-300.
3. Marel M, Stastny B, Melinova L, et al. Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990. Chest 1995;107:1598-603.
4. Prakash UB, Reiman HM. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985;60:158-64.
5. Nance KV, Shermer RW, Askin FB. Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination. Mod Pathol 1991;4:320-4.
6. Light RW. Tumor markers in undiagnosed pleural effusions. Chest 2004;126:1721-2.
7. Meyer T, Rustin GJ. Role of tumor markers in monitoring epithelial ovarian cancer. Br J Cancer 2000;82:1535-8.
8. Huang Y, Zimmerman RL, Bibbo M. Diagnostic value of CA 15-3 antibody in detecting metastatic adenocarcinoma. Anal Quant Cytol Histol 2004;26:259-62.
9. Molina R, Santabarbara P, FiIeIIa X, ef al. Relationship of CA 125 and CA 19.9 with lung carcinoma histological subtype: preliminary study. Int J Biol Markers 1989;4:215-20.
10. Barak V, Goike H, Panaretakis KW, et al. Clinical utility of cytokeratins as tumor markers. Clin Biochem 2004;37:529-40.
11. Bossuyt PM, Reitsma JB, Bruns DE, et al. Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003;326:41-4.
12. Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.
13. Deville WL, Buntinx F, Bouter LM, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2002;2:9.
14. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993;12:1293-316.
15. Jiang J, Shi HZ, Liang QL, et al. Diagnostic value of interferon-γ in tuberculous pleurisy: a metaanalysis. Chest 2007;131:1133-41.
16. Irwig L, Macaskill P, Glasziou P, et al. Meta-analytic methods for diagnostic test accuracy. J Clin Epidemiol 1995;48:119-30.
17. Vamvakas EC. Meta-analyses of studies of the diagnostic accuracy of laboratory tests: a review of the concepts and methods. Arch Pathol Lab Med 1998;122:675-86.
18. Suzuki S, Moro-oka T, Choudhry NK. The conditional relative odds ratio provided less biased results for comparing diagnostic test accuracy in meta-analyses. J Clin Epidemiol 2004;57:461-9.
19. Westwood ME, Whiting PF, Kleijnen J. How does study quality affect the results of a diagnostic meta-analysis? BMC Med Res Methodol 2005;8:20.
20. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. SMJ 1997;315:629-34.
21. Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. Am Fam Physician 2006;73:1211-20
22. Glas AS, Lijmer JG, Prins MH, et al. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003;56:1129-35.
23. Deeks JJ. Systematic reviews of evaluations of diagnostic and screening tests. In: Egger M, Smith GD, Altman DG, eds. Systematic reviews in health care. Metaanalysis in context. London: BMJ Publishing Group, 2001:248-82.
24. Jaeschke R, Guyatt G, Lijmer J. Diagnostic tests. In: Guyatt G, Rennie D, eds. Users' guides to the medical literature. A manual for evidence-based clinical practice. Chicago: AMA Press, 2002:121-40.
25. Booth SN, Lakin G, Dykes PW, et al. Cancer-associated proteins in effusion fluids. J Clin Pathol 1977;30:537-40.
26. Pettersson T, Klockars M, Froseth B. Neuron-specific enolase in the diagnosis of small-cell lung cancer with pleural effusion: a negative report. Eur Respir J 1988;1:698-700.
27. Petitti DB. Approaches to heterogeneity in meta-analysis. Stat Med 2001;20:3625-33.